Engineering a tumor-selective prodrug T-cell engager bispecific antibody for safer immunotherapy

MLA

Amelia C. McCue, et al. “Engineering a Tumor-Selective Prodrug T-Cell Engager Bispecific Antibody for Safer Immunotherapy.” MAbs, vol. 16, no. 1, Dec. 2024. EBSCOhost, https://doi.org/10.1080/19420862.2024.2373325.

APA

Amelia C. McCue, Stephen J. Demarest, Karen J. Froning, Michael J. Hickey, Stephen Antonysamy, & Brian Kuhlman. (2024). Engineering a tumor-selective prodrug T-cell engager bispecific antibody for safer immunotherapy. MAbs, 16(1). https://doi.org/10.1080/19420862.2024.2373325

Chicago

Amelia C. McCue, Stephen J. Demarest, Karen J. Froning, Michael J. Hickey, Stephen Antonysamy, and Brian Kuhlman. 2024. “Engineering a Tumor-Selective Prodrug T-Cell Engager Bispecific Antibody for Safer Immunotherapy.” MAbs 16 (1). doi:10.1080/19420862.2024.2373325.